Quick Answer
Perspective Therapeutics, Inc. reported Total Revenue of $5.92 million for fiscal year 2018.
Perspective Therapeutics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2018 | $5.92M | +24.4% |
| 2017 | $4.76M | -0.2% |
| 2016 | $4.77M | +3.5% |
| 2015 | $4.61M | +9.2% |
| 2014 | $4.22M | -6.8% |
| 2013 | $4.53M | -10.8% |
| 2012 | $5.07M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $2.19M | +27.3% | +4.6% |
| June 30, 2023 | $2.09M | -16.6% | +1.2% |
| March 31, 2023 | $2.06M | -29.1% | +20.2% |
| September 30, 2022 | $1.72M | — | -31.5% |
| June 30, 2022 | $2.50M | — | -13.9% |
| March 31, 2022 | $2.91M | — | +52.8% |
| December 31, 2018 | $1.90M | +24.0% | +21.9% |
| September 30, 2018 | $1.56M | +29.0% | -0.7% |
- Perspective Therapeutics, Inc. showed an increase of +24.4% in Total Revenue compared to the prior fiscal year.
- Over the 2012–2018 period, Perspective Therapeutics, Inc.’s total revenue has grown by 16.8% (from $5.07 million to $5.92 million).
- The most recent figure is from Perspective Therapeutics, Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on September 26, 2018.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: